CDKL5 and craniodiaphyseal dysplasia: To date, the majority of reported CDD patients have been predicted to carry loss-of-function mutations, such as nonsense, indels, or missense mutations abolishing CDKL5 kinase activity39, suggesting that our knockout and R59X knockin mouse models may carry a high translational relevance.